Capricor Therapeutics (CAPR) Institutional Ownership → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CAPR Stock Alerts $5.46 -0.07 (-1.27%) (As of 05:13 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Capricor Therapeutics (NASDAQ:CAPR)CurrentInstitutional OwnershipPercentage21.68%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$883.32KNumber ofInstitutional Sellers(last 12 months)0 Get CAPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Capricor Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CAPR Institutional Buying and Selling by Quarter Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Capricor Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/1/2024 BNP Paribas Financial Markets5,827$40K0.0%N/A0.018% 2/7/2024Jump Financial LLC52,800$258K0.0%N/A0.171% 12/6/2023Citigroup Inc.61,591$211K0.0%N/A0.200% 7/31/2023LPL Financial LLC78,436$375K0.0%N/A0.310% 5/1/2023Virtu Financial LLC16,895$71K0.0%N/A0.067% 11/7/2022Jump Financial LLC22,600$136K0.0%N/A0.093% Get the Latest News and Ratings for CAPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/18/2022Bailard Inc.33,601$202K0.0%+12.8%0.138% 7/27/2022Bailard Inc.29,801$104K0.0%N/A0.123% 4/20/2022 Selective Wealth Management Inc.213,494$732K0.3%N/A0.878% 11/16/2021Two Sigma Securities LLC11,511$46K0.0%N/A0.050% 11/15/2021 GSA Capital Partners LLP96,632$388K0.0%-14.0%0.420% 11/15/2021HighTower Advisors LLC53,960$215K0.0%+206.6%0.234% 11/9/2021Barclays PLC6,330$25K0.0%+246.1%0.027% 11/9/2021BlackRock Inc.300,201$1.21M0.0%-1.6%1.304% 8/17/2021Oracle Investment Management Inc.1,166,249$5.98M0.8%-41.7%5.098% 8/16/2021State Street Corp71,748$368K0.0%N/A0.314% 8/13/2021Northern Trust Corp104,251$535K0.0%+7.5%0.456% 8/13/2021Geode Capital Management LLC184,990$948K0.0%+7.9%0.809% 8/13/2021Vanguard Group Inc.923,233$4.74M0.0%+1.2%4.035% 8/11/2021Susquehanna Fundamental Investments LLC16,500$85K0.0%-49.1%0.072% 8/5/2021 GSA Capital Partners LLP112,364$576K0.1%+684.6%0.491% 5/18/2021Millennium Management LLC22,390$105K0.0%-54.6%0.098% 5/18/2021Oracle Investment Management Inc.1,999,464$9.36M1.4%N/A8.770% 5/12/2021Northern Trust Corp96,941$453K0.0%-29.1%0.425% 5/12/2021M Holdings Securities Inc.20,000$94K0.0%N/A0.088% 5/12/2021Geode Capital Management LLC171,415$802K0.0%+40.7%0.752% 5/10/2021HighTower Advisors LLC12,300$57K0.0%-25.9%0.054% 5/10/2021 GSA Capital Partners LLP14,321$67K0.0%-81.9%0.063% 5/7/2021BlackRock Inc.347,103$1.62M0.0%+1.2%1.523% 5/3/2021Trellus Management Company LLC270,000$1.26M0.7%N/A1.184% 2/11/2021Northern Trust Corp136,814$469K0.0%-9.6%0.669% 2/9/2021 Bank of New York Mellon Corp89,249$306K0.0%+47.7%0.436% 2/5/2021BlackRock Inc.343,011$1.18M0.0%+0.4%1.677% 2/4/2021 GSA Capital Partners LLP79,091$271K0.0%N/A0.387% 11/17/2020Jane Street Group LLC12,943$68K0.0%-51.1%0.066% 11/13/2020Morgan Stanley44,843$235K0.0%+26.4%0.227% 11/12/2020JPMorgan Chase & Co.5,607$30K0.0%+80,000.0%0.028% 11/6/2020BlackRock Inc.341,523$1.79M0.0%+900.8%1.732% 9/15/2020Two Sigma Advisers LP21,130$97K0.0%N/A0.107% 8/17/2020Jane Street Group LLC26,474$122K0.0%+9.6%0.134% The asset beating inflation by 4x (Ad)"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details8/12/2020Goldman Sachs Group Inc.38,808$179K0.0%N/A0.272% 8/10/2020HighTower Advisors LLC13,000$59K0.0%N/A0.091% 8/7/2020Virtu Financial LLC57,444$264K0.0%N/A0.403% 5/15/2020Jane Street Group LLC24,150$29K0.0%N/A0.194% (Data available from 1/1/2016 forward) CAPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CAPR shares? During the previous two years, the following institutional investors and hedge funds held shares of Capricor Therapeutics shares: LPL Financial LLC ($375K), Jump Financial LLC ($258K), Citigroup Inc. ($211K), Bailard Inc. ($202K), and Virtu Financial LLC ($71K), BNP Paribas Financial Markets ($40K).Learn more on CAPR's institutional investors. What percentage of Capricor Therapeutics stock is owned by institutional investors? 21.68% of Capricor Therapeutics stock is owned by institutional investors. Learn more on CAPR's institutional investor holdings. Which institutional investors have been buying Capricor Therapeutics stock? The following institutional investors have purchased Capricor Therapeutics stock in the last 24 months: LPL Financial LLC ($78.44K), Jump Financial LLC ($75.40K), Citigroup Inc. ($61.59K), Bailard Inc. ($33.60K), Virtu Financial LLC ($16.90K), and BNP Paribas Financial Markets ($5.83K). How much institutional buying is happening at Capricor Therapeutics? Institutional investors have bought a total of 271,750 shares in the last 24 months. This purchase volume represents approximately $1.22M in transactions. Related Companies: IVA Institutional Ownership SCPH Institutional Ownership GOSS Institutional Ownership PRQR Institutional Ownership RGLS Institutional Ownership CRVO Institutional Ownership MCRB Institutional Ownership OMER Institutional Ownership IXHL Institutional Ownership RIGL Institutional Ownership This page (NASDAQ:CAPR) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden replacement revealed?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.